CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Progestin Only Contraceptive Pillsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04965116
NCT04965116Phase 4Completed
CompareCT.gov

Progestin-Only Pill Use and Breastfeeding Study

University of California, San Diego·interventional·Posted Jul 16, 2021·Updated Apr 19, 2024

In Brief

A Phase 4 clinical trial evaluating Progestin Only Contraceptive Pills for Contraception and Breastfeeding. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study will assess the impact of early initiation (less than one week postpartum) and delayed initiation (4 weeks postpartum) of two types of progestin-only contraceptive pills (POPs) on maternal, breastmilk, and infant outcomes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception, Breastfeeding
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedJul 16, 2021
Enrollment StartOct 25, 2021
Primary CompletionNov 4, 2022
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 5.0 years ago

Interventions

Progestin Only Contraceptive Pillsdrug

Daily pill (placebo or active tablet)